Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial.

Saved in:
Bibliographic Details
Title: Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial.
Authors: Kim, Kyoo Hyun1 (AUTHOR), Hwang, Shinwon2 (AUTHOR), Kim, Min Kyoung3 (AUTHOR), Park, Keon-Uk4 (AUTHOR), Yun, Tak5 (AUTHOR), Lee, Keun-Wook6 (AUTHOR), Kim, Joo Hang7 (AUTHOR), Keam, Bhumsuk8 (AUTHOR), Cho, Byoung Chul1 (AUTHOR), Oh, So Yeon9 (AUTHOR), Cho, Sang Hee10 (AUTHOR), Kim, Sangwoo11,12 (AUTHOR), Kim, Sung-Bae13 (AUTHOR) sbkim3@amc.seoul.kr, Hong, Min Hee1 (AUTHOR) minhee_hong@yuhs.ac, Kim, Hye Ryun1,12 (AUTHOR) nobelg@yuhs.ac
Source: Cancer Research & Treatment. Oct2025, Vol. 57 Issue 4, p968-980. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15982998
DOI:10.4143/crt.2024.1195